AbbVie (ABBV) EBT Margin (QoQ) (2012 - 2026)
AbbVie (ABBV) EBT Margin (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.29 Bn | 631.53 Bn | 17.26 Bn |
| 2 | AbbVie | 470.62 Bn | 464.06 Bn | 12.70 Bn |
| 3 | Merck | 375.66 Bn | 368.52 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.90 Bn | 295.21 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.50 Bn | 252.60 Bn | 12.86 Bn |
| 6 | Amgen | 237.19 Bn | 223.20 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.92 Bn | 179.74 Bn | 6.22 Bn |
| 8 | Pfizer | 160.14 Bn | 148.44 Bn | 10.94 Bn |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn |
| 10 | Sanofi | 55.22 Bn | 47.84 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,825.00 |
| Mar 31, 2026 | -913.00 |
| Dec 31, 2025 | 1,153.00 |
| Sep 30, 2025 | -555.00 |
| Jun 30, 2025 | -237.00 |
| Mar 31, 2025 | 2,747.00 |
| Dec 31, 2024 | -2,944.00 |
| Sep 30, 2024 | -43.00 |
| Jun 30, 2024 | 58.00 |
| Mar 31, 2024 | 578.00 |
| Dec 31, 2023 | -555.00 |
| Sep 30, 2023 | -480.00 |
| Jun 30, 2023 | 1,494.00 |
| Mar 31, 2023 | -1,572.00 |
| Dec 31, 2022 | -1,010.00 |
| Sep 30, 2022 | 2,159.00 |
| Jun 30, 2022 | -2,830.00 |
| Mar 31, 2022 | 772.00 |
| Dec 31, 2021 | 298.00 |
| Sep 30, 2021 | 1,738.00 |